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ABSTRACT
Background. General population data were used to study co-morbidities between lifetime social
phobia and mood disorders.
Methods. Data come from the US National Comorbidity Survey (NCS).
Results. Strong associations exist between lifetime social phobia and major depressive disorder
(odds ratio 2–9), dysthymia (2–7) and bipolar disorder (5–9). Odds ratios increase in magnitude with
number of social fears. Reported age of onset is earlier for social phobia than mood disorders in
the vast majority of co-morbid cases. Temporally-primary social phobia predicts subsequent onset
of mood disorders, with population attributable risk proportions of 10–15%. Social phobia is also
associated with severity and persistence of co-morbid mood disorders.
Conclusions. Social phobia is a commonly occurring, chronic and seriously impairing disorder that
is seldom treated unless it occurs in conjunction with another co-morbid condition. The adverse
consequences of social phobia include increased risk of onset, severity and course of subsequent
mood disorders. Early outreach and treatment of primary social phobia might not only reduce the
prevalence of this disorder itself, but also the subsequent onset of mood disorders.
INTRODUCTION
Psychiatric co-morbidity is highly prevalent
among patients with mood disorders (Liebowitz
et al. 1985; Alpert et al. 1994) and is associated
with impairment and chronicity (Hecht et al.
1989; Wittchen & Essau, 1989). Co-morbid
anxiety has received the most attention in this
regard (Maser & Cloninger, 1990), with panic
(Reich et al. 1993; Kessler et al. 1998a) and
generalized anxiety disorder (Noyes et al. 1992;
Brawman-Mintzer et al. 1993) being the subjects
of special interest based on their strong
associations with mood disorders. However,
social phobia (sometimes referred to as social
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anxiety), the most commonly occurring anxiety
disorder among people with mood disorders
(Kessler, 1995; Merikangas et al. 1996), has
been comparatively neglected in research on co-
morbid mood disorders. This is presumably due
to the fact that social phobia is under diagnosed
(Liebowitz et al. 1985; Weiller et al. 1996; Fones
et al. 1998) and incorrectly regarded as not
seriously impairing (Judd, 1994; Hirschfeld,
1995; Wittchen & Beloch, 1996). The current
report helps address this oversight by presenting
epidemiological data on co-morbidity between
mood disorders and social phobia in the US
National Comorbidity Survey (NCS; Kessler et
al. 1994).
Previous studies have documented that social
phobia is significantly co-morbid with mood
disorders (Schneier et al. 1992; Lecrubier &
Weiller, 1997; Pini et al. 1997) and that social
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phobia is temporally primary in the vast majority
of these cases (Merikangas et al. 1996; Parker et
al. 1997). Social phobia has also been linked to
severity (Merikangas & Angst, 1995) and per-
sistence (Alpert et al. 1997) of mood disorders.
We expand the investigation of these issues here
in a number of ways. First, unlike many previous
studies, we control for other co-morbid con-
ditions in order to provide a clear evaluation of
the unique effects of social phobia on mood
disorders. Secondly, we introduce a number of
specifications aimed at disentangling contending
interpretations of previously documented
findings. Thirdly, unlike most previous studies
(for notable exceptions, see Angst, 1996 and Pini
et al. 1997), we present data separately on major
depressive disorder, dysthymia and bipolar
disorder in order to examine whether patterns
and correlates of co-morbidity vary across types
of mood disorder.
Four logical possibilities exist for explaining
the co-morbidity between mood disorders and
social phobia: that social phobia is a causal risk
factor for secondary mood disorders, that mood
disorders are risk factors for secondary social
phobia, that social phobia and mood disorders
are both consequences of some common cause,
and that methodological factors create an
artificial association between the two disorders.
Most clinical research has focused on the first
possibility. It has been postulated that persistent
anxiety leads to an exhaustion response that
eventually results in depression (Akiskal, 1990).
This supposition is at least superficially con-
sistent with two findings: (1) most patients with
a history of both disorders report that their
social phobia preceded the depression; and (2)
social phobia was a strong predictor of sub-
sequent depression in one prospective study
(Angst, 1996). Another prospective study docu-
mented a weaker predictive association (Parker
et al. 1997).
If this causal interpretation were correct, we
would expect a dose-response relationship be-
tween temporally-primary social phobia and the
subsequent onset, course, and severity of sec-
ondary mood disorders. Data on this possibility
are presented here that distinguish between the
large group of social phobics found in previous
NCS analyses to have exclusive performance
fears associated with public speaking and others
who have a more generalized form of social
phobia (Kessler et al. 1998b). If secondary
depression was a consequence of prior social
phobia, we would expect the more generalized
form of social phobia to more powerfully predict
onset, course and severity of secondary mood
disorders.
Furthermore, if secondary mood disorders
were the result of exhaustion or demoralization
in the face of persistent and intractable anxiety,
we would expect that chronic anxiety not merely
occasional anxiety precipitates secondary mood
disorders. Risk of mood disorders would
expectedly increase with the duration of the
social phobia. If social phobia is a genuine risk
factor we would also expect that only currently
active social phobia not remitted social phobia
would predict the subsequent onset, course, and
severity of secondary mood disorders. If, on the
other hand, social phobia is a marker of risk
rather than a true risk factor (Kraemer et al.
1997), remitted social phobia might continue to
elevate risk of mood disorders. The same pattern
might exist if social phobia is a phase in a
distinct biologically determined anxiety-mood
disorder. All of these specifications are examined
in the present report.
METHOD
Sample
The NCS is a nationally representative house-
hold survey of persons ages 15 to 54 in the non-
institutionalized civilian population of the 48
coterminous United States along with a rep-
resentative supplemental sample of students
living in campus group housing. The NCS was
administered to 8098 respondents between 14
September 1990 and 6 February 1992 in face-to-
face in-home interviews. The response rate was
82–4%. The data reported here have been
weighted to adjust for differential probabilities
of selection and non-response. Additional details
of the NCS design, field procedure and sample
weights are reported elsewhere (Kessler et al.
1994, 1995a).
Diagnostic assessment
NCS diagnoses are based on a modified version
of the Composite International Diagnostic In-
terview (CIDI; WHO, 1990), a fully structured
interview designed to be administered by inter-
viewers who are not clinicians and to generate
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diagnoses according to the definitions and
criteria of both DSM-III-R (APA, 1987) and
ICD-10 (WHO, 1991). DSM-III-R criteria are
used in the current report. The disorders of
primary interest are social phobia, major de-
pressive disorder, dysthymia and bipolar dis-
order. However, we also control for co-
morbidities with the other DSM-III-R disorders
assessed in the NCS, including other anxiety
disorders (panic disorder, other phobias,
generalized anxiety disorder, post-traumatic
stress disorder), substance use disorders (alcohol
and drug abuse and dependence) and non-
affective psychosis. Results for these controls are
not reported in the tables in order to avoid
undue complexity. However, detailed data on
the magnitude of co-morbidities among all the
NCS disorders are reported elsewhere (Kessler,
1997).
An NCS clinical reappraisal study of the
CIDI was carried out (Kessler et al. 1998c) that
found good test–retest reliability for all
diagnoses and good validity compared to blind
clinical reinterviews for all diagnoses with the
exceptions of mania (Kessler et al. 1997) and
non-affective psychosis (NAP; Kendler et al.
1996). In the case of mania, we found that the
CIDI had great difficulty accurately classifying
respondents who reported irritability rather than
euphoria as their master symptom, while the
subset of cases with a euphoric–grandiose
symptom profile were classified with very good
accuracy. Therefore, only the subset of
respondents with a euphoric–grandiose symp-
tom profile were classified as having bipolar
disorder for the purposes of this report. In the
case of NAP, we found that the judgements
about presumed delusions required to be made
by lay interviewers based on open-ended reports
of respondents had very low clinical validity.
Therefore, clinical reinterviews were attempted
with all respondents classified as having NAP by
the CIDI to confirm the diagnoses.
As separate clinical reappraisal interviews
were carried out for each diagnosis and di-
agnostic hierarchy ruleswere not used in carrying
out the clinical reappraisal interviews, no data
are available on the CIDI’s accuracy in dis-
criminating between unipolar and bipolar de-
pression or between depression and panic in the
NCS. The absence of such data is a limitation of
these results.
Earlier WHO CIDI field trials found only
marginally acceptable validity compared to
clinician assessments of retrospective diagnostic
age of onset reports (Wittchen et al. 1989). This
is an important limitation because age of onset
plays a central role in the analysis of temporal
priorities between lifetime co-morbid disorders.
In order to improve the accuracy of these
reports in the NCS, the standard CIDI age of
onset question, which simply asks respondents
how old they were when they first had an
episode of depression or a panic attack or a
cluster of four panic attacks in a single month,
was elaborated into a series of three more
focused questions. The first question asked
respondents if they could ‘CLEARLY RE-
MEMBER (emphasis in original) ’ the exact age
when they had their first episode or attack or
attack cluster. If so, that age was recorded. If
not, they were asked their approximate age at
onset : ‘ABOUT (emphasis in original) how old
were you the first time?’. They were then asked
for ‘ the earliest age you can CLEARLY RE-
MEMBER (emphasis in original) ’ a particular
episode or attack or attack cluster. The response
to this last question was taken as an upper
bound on the respondent’s age of onset. In the
case of respondents who reported multiple social
fears, age of onset was dated for the earliest of
these fears.
No data to assess the comparative validity of
the age of onset reports based on this three-
question series were obtained in the NCS clinical
reappraisal study. However, the substantively
implausible associations between age at inter-
view and reported age of onset found in surveys
that use the standard CIDI age of onset question
(Simon & VonKorff, 1995) does not exist in the
NCS (Knauper et al. 1999), indirectly arguing
for an improvement in validity based on the use
of the more complex age of onset questions.
Nonetheless, the likely existence of remaining
error in NCS retrospective age of onset reports
should be considered a limitation of these results.
Analysis procedures
The CIDI includes questions about six social
phobia trigger situations: speaking in public ;
having to use the toilet when away from home,
eating or drinking in public ; talking to people
when you might have nothing to say or might
sound foolish; writing while someone watches ;
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and talking in front of a small group of people
(‘small ’ was not defined). A previously reported
latent class analysis of the multivariate
associations among these fears found two social
phobia latent classes : one characterized by pure
speaking fears (endorsement of only the first
and}or last of the six items) ; and another
characterized by a more general set of social
fears (Kessler et al. 1998b). Based on this finding,
the results reported below distinguish between
social phobics with pure speaking fear (35–8%
of all social phobics in the NCS) and other social
phobics (64–2%). Within the subsample of social
phobics with pure speaking fears, we also
distinguish between those who have an exclusive
fear of public speaking (21–8% of all social
phobics), which is by far the most common
exclusive social fear, and those who also have a
fear of speaking in small groups (14–0%). Within
the subsample of social phobics with other social
fears, we distinguish between those who have
only one fear (8–5%), two fears (15–9%), and
three or more fears (39–6%).
Conditional probabilities and odds-ratios
were used to study co-morbidity. Retrospective
age of onset reports were used to study temporal
priorities between first onsets. Discrete-time
survival analysis with person-year as the unit of
analysis was used to study predictive associations
between temporally primary social phobia and
secondary mood disorders. In this method, each
year in the life of each respondent up to and
including the year of onset of the mood disorder
or the year of interview, whichever comes first, is
treated as a separate observational record.
Logistic regression was used to predict a
dichotomous measure of onset of the outcome
disorder (coded one for the year of onset and
zero for prior years) in this person-year file.
When controls are introduced for age at time of
the observational record, the logistic regression
coefficients can be interpreted as survival
coefficients in a model that allows non-
proportional hazards (Efron, 1988). These
coefficients can also be exponentiated to generate
odd ratios (ORs). The predictors can be either
unrelated to time, such as gender or race, or
time-varying, such as marital status or history of
other disorders.
In our use of the discrete-time survival
method, we estimated a separate series of models
to predict lifetime first onset of three outcomes:
major depressive disorder, dysthymia and bi-
polar disorder. In each model we included
controls for age in the person-year, age at
interview, gender and race. The predictors of
primary interest were time-varying measures of
the prior onset and continuation of social
phobia. These were ‘ time-varying’ in that they
were coded as not present for the observational
records for a particular respondent up to the age
of onset of social phobia and then coded as
present in subsequent observational records. We
also elaborated this coding to create predictor
variables that indicated how many years it had
been since first onset of social phobia. We used
respondent reports about age of recency of
social phobia to create predictor variables that
distinguished observational records charac-
terized by a history of remitted social phobia
and active social phobia. Controls for other co-
morbid DSM-III-R disorders in the NCS that
had onsets prior to or in the same year as social
phobia were also included in the equations.
Significant tests for individual ORs were
computed using the method of jackknife re-
peated replications (JRR; Kish & Frankel, 1974)
to estimate standard errors that adjusted for
design effects introduced by clustering and
weighting of observations. JRR is one of several
methods that use simulations of coefficient distri-
butions in subsamples to generate empirical
estimates of standard errors and significance
tests. The ratios of the coefficients to these
adjusted standard errors were used to compute z
tests for the significance of the survival
coefficients and 95% confidence intervals for
the ORs. Tests for the significance of sets
of predictors taken together were computed
using Wald chi-square tests from coefficient
variance–covariance matrices based on the JRR
simulations.
RESULTS
Co-morbidities between social phobia and mood
disorders
The lifetime (LT) prevalence of DSM-III-R
social phobia and mood disorders in the NCS
have been reported previously (Kessler et al.
1994, 1997, 1998b). They include 13–3% for
social phobia, 14–9% for major depressive
disorder, 2–8% for dysthymia, 0–4% for the
euphoric–grandiose subtype of bipolar disorder
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Table 1. The lifetime prevalences of social phobia among NCS respondents with lifetime mood
disorders
Major depression Dysthymia Bipolar disorder Any mood disorder Total sample
% OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) % (N )
Pure speaking phobia
Public speaking only 5–0 2–4* (1–5–3–6) 3–1 1–3 (0–5–3–6) 0–0 — (—) 4–4 2–0* (1–3–3–1) 2–9 236
Broader speaking fears 4–0 3–2* (1–8–5–6) 2–6 1–7 (0–6–4–8) 0–0 — (—) 3–8 3–1* (1–8–5–4) 1–9 151
Total 9–0 2–7* (1–8–4–0) 5–7 1–5 (0–7–3–0) 0–0 — (—) 8–1 2–4* (1–6–3–6) 4–8 387
Other social phobia
1 fear 2–5 3–4* (1–7–6–9) 1–3 1–4 (0–4–5–1) 5–3 7–9* (2–0–31–6) 2–4 3–4* (1–8–6–7) 1–1 92
2 fears 4–0 2–7* (1–8–4–1) 5–1 3–1* (1–6–6–0) 8–2 6–4* (1–6–26–3) 4–0 2–8* (1–8–4–3) 2–1 171
& 3 or more fears 11–0 3–1* (2–4–4–0) 16–4 4–0* (2–4–6–9) 33–6 10–7* (2–7–42–3) 12–1 3–8* (3–0–4–8) 5–3 428
Total 17–5 3–0* (2–4–3–8) 22–8 3–4* (2–1–5–4) 47–1 9–3* (2–8–30–6) 18–5 3–5* (2–8–4–2) 8–5 691
Any social phobia 26–5 2–9* (2–3–3–6) 28–5 2–7* (1–9–3–8) 47–1 5–9* (1–8–19–6) 26–6 3–1* (2–5–3–8) 13–3 1078
* Significant at the 0–05 level.
 The percentage columns report the lifetime prevalences of social phobia among respondents with a history of mood disorders. For
example, the 5% in the upper left corner of the table means that 5% of the NCS respondents with a lifetime history of major depression also
had a history of pure public speaking social phobia.
 The OR columns report odds ratios between lifetime social phobia and mood disorders. Entries for subtypes exclude other subtypes from
the calculations. For example, the 2–4 odds ratio between pure public speaking social phobia and major depression excludes respondents with
other social phobia subtypes.
and 17–1% for any mood disorder. We also
consider social phobia subtypes, including
respondents who report exclusive social fears
associated with public speaking (2–9% of the
population) broader speaking fears (1–9%) and
types with either one (1–1%), two (2–1%), or
three or more (5–3%) social fears not exclusively
involving speaking in the CIDI.
As shown in Table 1, somewhat more than
one-quarter of respondents with lifetime major
depression (26–5%) or dysthymia (28–5%) and
nearly half of those with bipolar disorder
(47–1%) also meet lifetime criteria for social
phobia. Although the results in the table are not
percentaged from the perspective of mood
disorders, transformation shows that 34–2% of
lifetime social phobics reported a lifetime mood
disorder compared to 14–5% of respondents
who did not have social phobia. The ORs
between social phobia and lifetime mood
disorders are 2–9 for major depression, 2–7 for
dysthymania and a substantially higher 5–9 for
bipolar disorder. ORs are consistently lowest for
social phobia associated with pure fear of public
speaking. It is noteworthy that the pure public
speaking OR with any mood disorder (2–0) is
considerably less than the odds ratio associated
with other pure social fears (3–4), indicating that
it is not merely having only one social fear, but
also the nature of that fear, that is relevant for
co-morbidity with mood disorders. It is further
noteworthy that there are no cases of pure
speaking phobia among bipolars. Given the
higher prevalence of social phobia and mood
disorders among women than men in the NCS
(Kessler et al. 1994), we tested for sex differences
in the odds ratios reported in Table 1. None of
the 29 odds ratios was found to differ signifi-
cantly by sex at the 0–05 level of significance
(results not shown).
Temporal priority between social phobia and
mood disorders
Retrospective age of onset reports were
compared to assess the temporal priority of first
onsets of social phobia and mood disorder. As
shown in Table 2, 68–5% of respondents with a
history of both said the social phobia occurred
at an earlier age than the mood disorder
compared to 21–9% who said the mood disorder
occurred at an earlier age than the social phobia.
The remainder reported onsets of both disorders
at the same age. The mean of the absolute value
of the difference in ages of onset among all
respondents with a history of both social phobia
and a mood disorder was 7–2 years (with a
standard error of 0–8 years), while the mean
difference was 12–3 years (0–8) in the subsample
in which social phobia occurred earlier than
mood disorder and 7–7 (1–1) in the subsample
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Table 2. Temporal ordering of age of onset of social phobia and mood disorders among NCS









Social phobia temporally primary* 71–9 76–0 47–0 68–5
Mood disorder temporally primary* 18–4 17–8 40–7 21–9
Same-year onset of both disorders 9–7 6–1 12–3 9–6
* Reported age of onset at least 1 year prior to that of the other disorder.
Table 3. The effects of temporally primary social phobia in predicting first onset of mood
disorders
Major depression Dysthymia Bipolar disorder Any mood disorder
% OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI)
Pure current speaking phobia
Public speaking only 3–2 2–1* (1–4–3–2) 2–2 1–5 (0–6–3–8) 0–0 — — 2–7 1–7* (1–1–2–7)
Broader speaking fear 2–5 2–5* (1–5–4–1) 2–1 2–3 (0–7–7–3) 0–0 — — 2–4 2–4* (1–5–4–1)
Other current social phobia
1 fear 1–0 1–6 (0–8–3–0) 0–4 0–6 (0–1–5–9) 4–2 5–7 (0–9–34–7) 1–0 1–6 (0–9–2–9)
2 fears 3–0 2–4* (1–5–3–9) 4–2 3–8* (1–7–8–5) 6–5 5–1 (0–8–31–4) 2–9 2–3* (1–5–3–6)
& 3 fears 8–9 2–9* (2–3–3–6) 14–1 4–5* (2–6–7–7) 16–0 3–3 (0–8–13–5) 9–3 3–2* (2–5–4–2)
Any current social phobia 18–7 2–5* (2–0–3–1) 23–0 3–1* (2–2–4–4) 26–8 2–6 (0–7–9–0) 18–4 2–5* (2–0–3–1)
PARP 10–1 15–5 15–3 9–6
(s.e.) (1–6) (3–1) (13–4) (1–6)
v#
"
due to any current social phobia 60–2* 37–4* 2–9 62–1*
v#
%
due to current social phobia
subtypess
4–9 5–0 2–3 dffl 2 15–9*
v# due to non-active (remitted) social
phobia+
12–7* dffl 5 3–3 dffl 1 8–5* dffl 1 6–7 dffl 5
* Significant at the 0–05 level.
 The percentage columns report the prevalences of current social phobia in the year of onset of the mood disorder.
 Odds ratios were estimated in discrete-time survival models controlling for prior (to social phobia) history of other NCS}DSM-III-R
disorders and sociodemographic variables.
 PARP (Population Attributable Risk Proportion) was computed by simulation to estimate the expected reduction in the lifetime
prevalence of mood disorders if the estimated effects of social phobia were causal and the prevalence of social phobia was reduced to zero.
See Kessler et al. (1997) for a more complete discussion of estimation procedures.
 Significance test with one degree of freedom for the effect of any current social phobia in predicting subsequent onset of mood disorder.
s Incremental significance test with four degrees of freedom for the effects of current social phobia subtypes v. any social phobia in
predicting subsequent onset of mood disorder.
+ Significance test for the effects of remitted social phobia in predicting subsequent onset of major depression (dffl 5), dysthymia
(dffl 1), bipolar disorder (dffl 1), any mood disorder (dffl 5).
where mood disorder occurred earlier than social
phobia. As in Table 1, the pattern is different for
mania than the other mood disorders. The
proportion of co-morbid cases that reported
temporal priority of social phobia before mania
(47–0%) is not meaningfully higher than the
proportion that reported mania before social
phobia (40–7%). The situation is different for
major depression and dysthymia, where the
proportions reporting temporally primary social
phobia (71–9% and 76–0%, respectively) are
dramatically higher than the proportions
reporting primary mood disorders (9–7% and
6–1%, respectively).
The 9–6% of same-year onsets is nearly six
times as high as one would expect on the basis of
chance alone. There are a number of plausible
interpretations of this finding, two of which can
be examined in the NCS data. One is that it is
due to bias in the recollection of onset ages as
being the same when they actually differed. In
order to test this hypothesis, we focused on
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respondents who reported a first onset of mood
disorder at a particular age and an onset of
social phobia either before this age or at the
same age as the onset of the mood disorder. If
recall bias was at work, we would expect that the
proportion of respondents who recalled same-
year onsets would increase as age at interview
increases (i.e. length of recall period) controlling
for age of onset of mood disorder. No such
effect was found (results not shown). A second
possibility is that same-year onsets are due to
traumatic life events that precipitate both social
phobia and mood disorder. In order to test this
hypothesis, we compared reported ages of onset
of social phobia and mood disorders with reports
from other sections of the NCS about the
lifetime occurrence and ages of exposure to
traumatic life events. We found that 36–0% of
respondents with same-year onsets of social
phobia and mood disorder reported a traumatic
life event in this year compared to 8–0% of
respondents who reported different years of
onset of social phobia and mood disorder.
The effects of social phobia on the onset of
mood disorders
As noted above, discrete-time survival analysis
with person-year as the unit of analysis was used
to study the time-lagged effects of temporally
primary social phobia in predicting the sub-
sequent first onset of mood disorders. The
models controlled for prior (to social phobia)
history of other NCS}DSM-III-R disorders as
well as for basic sociodemographics (age, cohort,
sex, race-ethnicity). Results are shown in Table
3. Current social phobia significantly predicts
mood disorders overall (v#
"
fl 62–1, P! 0–001)
as well a major depression (v#
"
fl 60–2, P!
0–001) and dysthymia (v#
"
fl 37–4, P! 0–001),
with ORs ranging between 2–5 and 3–1 across
these different outcomes. There is no significant
effect on bipolar disorder (v#
"
fl 2–9, Pfl 0–089)
due to the small number of bipolars in the study,
but the 2–6 OR linking primary social to the
subsequent onset of bipolar disorder is none-
theless in the range found for the other mood
disorders. (The OR for any mood disorder (v#
%fl 15–9, P! 0–001), but not for any of the three
types of mood disorder, varies as a function of
number and type of social fears, with the
strongest OR found among social phobics
having three or more social fears (3–2) and the
lowest among social phobics with only one far
(1–6–1–7).) Population attributable risk pro-
portions of mood disorders associated with
prior social phobia range between 9–6% and
15–5% across outcomes.
More detailed analyses investigated three
potentially important elaborations of these
results. First, the effects of non-active remitted
social phobia were found to be much less
powerful than those of active ongoing social
phobia. Remitted social phobia has no
significant effect in predicting first onset of either
mood disorders (v#
&
fl 6–7, Pfl 0–244) or
dysthymia (v#
&
fl 3–3, Pfl 0–653) and sub-
stantively modest effects in predicting major
depression (v#
&
fl 12–7, Pfl 0–026) and bipolar
disorder (v#
"
fl 8–5, Pfl 0–003). Secondly, as
shown in Table 4, the effects of persistent social
phobia do not vary significantly with time since
first onset other than for same-year onsets. The
number of NCS respondents with bipolar dis-
order was too small to carry out this analysis,
but the results for major depression, dysthymia,
and any mood disorder are consistent in showing
that the ORs do not become larger as the
duration of social phobia increases. Thirdly, we
found no evidence that the effects of social
phobia vary by cohort or by age of onset of the
mood disorder. However, there was a signifi-
cantly (v#
"
fl 7–9, Pfl 0–005) more powerful OR
of social phobia in predicting subsequent early-
onset (defined as onset prior to age 25) dysthymia
(ORfl 4–4, 95% CIfl 2–9–6–7) than later-onset
dysthymia (ORfl 1–9, 95% CIfl 1–1–3–2).
The effects of social phobia on major depression
symptom profiles
Previous analysis of depressive symptoms in the
NCS found a clear distinction between
respondents with a typical vegetative symptom
profile and those with a more atypical reverse
vegetative symptom profile (Sullivan et al. 1998).
Based on previous evidence that social phobia
might be associated with atypical depression
(Alpert et al. 1997), we estimated a model to
determine whether prior history of social phobia
or particular social phobia subtypes dis-
criminates depression with a typical versus
atypical symptom profile. No such evidence was
found (results not shown).
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Table 4. The effects of duration of temporally primary active}current social phobia in predicting
first onset of mood disorder
Duration (in years) since
Major depression Dysthymia Any mood disorder
first onset of social phobia % OR (95% CI) % OR (95% CI) % OR (95% CI)
0 2–5 6–0* (3–6–9–8) 1–9 5–2* (2–1–13–1) 2–5 5–9* (3–6–9–7)
1–3 3–1 2–9* (1–9–4–5) 1–5 1–6 (0–3–7–1) 2–8 2–5* (1–7–3–8)
4–6 2–5 2–3* (1–4–3–7) 4–1 4–1* (1–9–8–8) 2–8 2–5* (1–7–3–8)
7–9 2–5 2–4* (1–5–3–9) 3–4 3–8* (1–8–7–8) 2–3 2–3* (1–5–3–5)
& 10 8–1 2–1* (1–6–2–7) 12–1 2–9* (1–6–2–7) 8–0 2–2* (1–6–2–9)
* Significant at the 0–05 level.
 Odds ratios were estimated in discrete-time survival models controlling for prior (to social phobia) history of other NCS}DSM-III-R
disorders and sociodemographic variables.
 The percentage columns report the prevalences of social phobia duration in the year of onset of the mood disorder.




Public speaking Broader speaking
only fears 1 or 2 fears 3 or more fears Any social phobia
% OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) v#
Attempt suicide 1–5 0–3 (0–1–1–0) 1–3 0–3 (0–0–1–5) 4–5 1–0 (0–3–3–0) 15–3 1–7 (0–9–3–2) 22–5 1–0 (0–6–1–7) 6–5
See any prof. 3–3 1–0 (0–4–2–3) 2–4 0–9 (0–2–3–2) 5–3 2–3* (1–0–5–0) 10–8 1–7 (0–9–3–1) 21–9 1–5 (1–0–2–3) 7–3
Interfere a lot 1–8 0–4* (0–2–0–8) 2–2 0–7 (0–2–2–3) 5–0 1–3 (0–5–3–1) 12–8 1–9* (1–0–3–5) 21–8 1–2 (0–7–2–0) 12–8*
Impaired work 3–5 1–2 (0–4–3–4) 2–5 0–7 (0–2–3–0) 5–4 1–9 (0–8–4–7) 11–6 2–1 (1–1–2–9) 23–1 1–6 (0–9–2–8) 8–7
Was hospitalized 7–7 3–0 (1–0–9–3) 1–3 0–4 (0–1–2–0) 4–6 1–2 (0–3–4–7) 17–5 1–9 (0–9–4–3) 31–1 1–6 (0–8–3–2) 8–8
Any impairment 3–2 0–9 (0–3–2–6) 2–6 0–8 (0–1–4–9) 5–1 2–0 (0–8–5–2) 11–8 3–2* (1–6–6–1) 22–7 1–8* (1–1–3–0) 16–0*
— 0–8 (0–5–1–4) — 0–6 (0–3–1–2) — 1–4 (0–9–2–1) — 1–8 (1–2–2–6) — 1–3 (0–9–1–8) 17–2*
* Significant at 0–05 level.
 Odds ratios were estimated in logistic regression models controlling for prior (to social phobia) history of other NCS}DSM-III-R
disorders, sociodemographics, age of onset of mood disorder, and number of years since onset of mood disorder.
 v# tests evaluate the significance of the set of predictors associated with social phobia subtypes.
 The percentage columns report the prevalences of each severity indicator among respondents with a history of social phobia.




Public speaking Broader speaking
only fears 1 or 2 fears 3 or more fears Any social phobia
% OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) v#
& 10 lifetime episodes 3–6 1–3 (0–3–6–3) 1–0 0–2 (0–0–2–5) 5–6 1–4 (0–6–3–3) 17–4 2–7* (1–2–6–1) 27–6 1–7* (0–9–3–2) 10–1*
Chronic episode (& 2 years) 2–9 0–8 (0–3–2–5) 1–8 0–6 (0–2–1–9) 2–0 0–4 (0–1–1–2) 11–7 1–3 (0–6–2–9) 18–4 0–9 (0–5–1–6) 4–2
Depression in past 30 days 4–9 1–9 (0–6–6–2) 1–2 0–4 (0–1–1–6) 5–9 1–5 (0–6–4–0) 16–0 2–5* (1–4–4–4) 28–0 1–7* (1–0–2–9) 11–7*
* Significant at 0–05 level.
 Odds ratios were estimated in logistic regression models controlling for prior (to social phobia) history of other NCS}DSM-III-R
disorders, sociodemographics, age of onset of mood disorder and number of years since onset of mood disorder.
 v# tests evaluate the significance of the set of predictors associated with social phobia subtypes.
 The percentage columns report the prevalences of each course indicator among respondents with a history of social phobia.
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The effects of social phobia on the severity of
major depression
The results in Table 5 show the effects of
temporally primary social phobia in predicting
severity indicators of major depression. As in
Tables 3 and 4, the models controlled for prior
(to social phobia) history of other NCS}DSM-
III-R disorders as well as for sociodemographics.
We also controlled for age of onset of depression
and number of years between onset and the time
of interview. Parallel analyses of social phobics
with co-morbid dysthymia or mania could not
be carried out due to small sample sizes. The
table documents a generally positive pattern of
associations between overall social phobia and
seeing a professional for depression, interference
with life activities due to the depression, work
impairment due to the depression, being
hospitalized for depression and reporting at
least one of these severity indicators. However,
the significant 1–8 OR between any social phobia
and any depression impairment is due entirely to
respondent with 1–2 (ORfl 2–0) or & 3 (ORfl
3–2) social fears. There is no consistent evidence
for any elevated depression severity indication
associated with social phobic having only one
fear. Neither is social phobia of any sort
associated with elevated risk of suicide attempts
during depressive episodes.
The effects of social phobia on the course of
major depression
The results in Table 6 show the effects of
temporally primary social phobia in predicting
several indicators of the course of major de-
pression. The same controls as those in Table 5
were included in these models. Social phobia
with & 3 social fears is found to be associated
with significantly elevated odds of having a large
number (& 10) of depressive episodes (ORfl
2–7) and of current depression (2–5), but not with
a history of chronic depression (defined as an
episode lasting 2 years or longer). Pure speaking
social phobia and social phobia with only 1–2
non-speaking fears are not associated with any
of these indicators of course. Parallel analyses of
social phobics with co-morbid dysthymia or




Five limitations of the above results have to be
noted. First, the NCS is a cross-sectional survey,
which means that inferences about temporal
ordering are based on retrospective reports. As
noted in the methods section, we attempted to
improve accuracy of age of onset reporting.
However, errors doubtlessly remain that would
have been reduced either if we had used a life
chart scheme to anchor retrospective reports
(e.g. Lyketsos et al. 1994; Hunt & Andrews,
1995) or if we had used longitudinal data.
Secondly, the CIDI is a lay-administered di-
agnostic interview that only imperfectly captures
the diagnostic distinctions made by experienced
clinicians. The evidence of good consistency of
the CIDI with independent clinical diagnoses
argues against a pervasive bias, but it remains
possible that CIDI imprecision affects results.
Thirdly, the CIDI focuses largely on lifetime
disorders. As a result, we have been concerned
here with temporal ordering of first onsets and
have said nothing about the order of onset of
social phobia and mood disorders in particular
episodes. There is no reason to think that
temporal priority in first onset will tell us much
about temporal priority in episodes. Fourthly,
the results reported here apply mostly to the
roughly two-thirds of co-morbid social phobias
with mood disorder whose mood disorder
occurred subsequent to the onset of their social
phobia. Fifthly, as parallel analyses were not
carried out for other anxiety disorders, there is
no information in this report to suggest that the
effects on mood disorder are specific to social
phobia. It might well be that other anxiety
disorders have similar or greater effects. As we
controlled for all other NCS}DSM-III-R
disorders in the analyses, though, the results
reported here are not due to those other
disorders.
Consistency with previous research
Within the context of these limitations, the basic
results found here are very similar to those of
previous research in documenting strong lifetime
co-morbidities between social phobia and mood
disorders. However, our finding in Table 1 that
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lifetime co-morbidity is stronger for bipolar
than unipolar depression is inconsistent with at
least one cross-sectional clinical study that
found social phobia to be relate to unipolar, but
not bipolar, depression (Pini et al. 1997). This
inconsistency might be related to the fact that, as
shown in Table 2, social phobia is much more
likely to occur after bipolar depression than
other mood disorders. This means that it might
require long-term follow-up of clinical samples
of bipolars to detect the strong association with
social phobia documented in Table 2. The reason
for this difference between bipolar and non-
bipolar depression is unclear. No efforts were
made to investigate reasons for the difference
due to the small number of bipolars (Nfl 32)
and very small number of bipolars with
comorbid social phobia (Nfl 15) in the NCS.
Our results are similar to those of previous
studies (Merikangas et al. 1996; Parker et al.
1997) in finding a clear temporal priority of
social phobia before non-bipolar mood dis-
orders. Our results are also consistent with
others (Merikangas & Angst, 1995; Alpert et al.
1997) in finding significant associations of
temporally primary social phobia with the
subsequent onset, severity and course of de-
pressive disorders. Unfortunately, most of our
analyses of these outcomes were restricted to
non-bipolar mood disorders due to the small
number of confirmed bipolars in the NCS. We
found some variation in the effects in predicting
severity, although this variation might be due to
chance in such a large number of replications.
We also found some variation with regard to
course. Specifically, while primary social phobia
is significantly associated with having a large
number of depressive episodes, it is unrelated to
whether any of these episodes persists long
enough (2 years or more) to be classified as
chronic. Again, though, this variation might be
due to chance. It is consequently important that
these results be replicated in independent
epidemiological datasets. We failed to replicate
the finding of one previous study that social
phobia is more strongly related to early-onset
than later-onset depression (Parker et al. 1997)
and the finding of another study that social
phobia is more strongly associated with atypical
than typical symptoms of depression (Alpert et
al. 1997).
Several potentially important specifications
are notable. The first is that the relationships of
primary social phobia with onset, severity, and
course of any mood disorder vary with number
of social fears. Pure public speaking social
phobia and social phobia associated with only
one other social fear are the least powerful
predictors of onset and are not significantly
related to severity or course of mood disorders.
Social phobia with three or more non-exclusive
speaking fears is the most powerful and con-
sistent predictor of these various outcomes.
These results are consistent with the findings of
previous studies that only generalized social
phobia substantially interferes with role
functioning and quality of life (Kessler et al.
1998b ; Wittchen et al. 1998). However, it is
important to recognize, in considering the results
regarding social phobia subtypes in the NCS,
that we cannot clearly distinguish DSM-III-R
generalized social phobia due to the fact that the
CIDI does not include questions about inter-
actional fears or a large enough set of questions
about overall social fears to operationalize the
DSM requirement for the generalized subtype
that respondents must have excessive fears of
‘most ’ social situations. It is conceivable, then,
that more detailed assessment in future surveys
will show that the effects of social phobia are
confined to the even smaller subset of cases with
generalized social phobia.
Another noteworthy specification involves the
association between duration of primary social
phobia and onset of subsequent mood disorder.
Consistent with previous NCS analyses that
have documented strong same-year associations
between first onset of mood disorders and first
onset of other co-morbid conditions (Kessler et
al. 1996), we found that mood disorders have
their highest conditional odds of onset in the
year of onset of social phobia. It is not clear why
this is the case. Nor does it mean that the same-
year onsets are coincident. It might be that
social phobia typically has an onset earlier than
mood disorder within the same year. One
otherwise plausible possibility, that the strong
same-year association is due to recall bias, is
inconsistent with results reported above that
length of the recall period is unrelated to
probability of reporting same-year onset. A
second possibility is that some acute traumatic
life experience triggered onsets of both disorders
in some cases of this sort. This is consistent with
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our finding that a high proportion of NCS
respondents with PTSD report the onset of
diverse anxiety and mood disorders as occurring
in the same year as the onset of their PTSD
(Kessler et al. 1995b). It is also consistent with
the finding that 30–0% of respondents with
same-year onsets reported a traumatic life event
in this year elsewhere in the NCS compared to
8–0% of respondents who reported different
years of onset of social phobia and mood
disorder. Another possibility is that the same-
year clustering of social phobia and mood
disorder onsets represents diagnostic confusion
between social phobia and depression with
rejection sensitivity (Katschnig, 1996). We have
no way of evaluating this possibility in the NCS,
but it is an issue that is worthy of investigation
in future epidemiological studies.
Aside from this strong same-year clustering,
we failed to find evidence of a change in the
association between primary social phobia and
subsequent mood disorders as a function of the
duration of the phobia. This is an important
finding from the perspective of secondary mood
disorder because it means that elevated risk of
such disorders persists for many years after the
onset of social phobia. This finding is at least
superficially inconsistent with the widely
proposed, but previously untested, hypothesis
that secondary depression often occurs as an
exhaustion response to persistent anxiety
(Akiskal, 1990). It should be noted, though, that
this proposed mechanism might be more plaus-
ible in accounting for the effects on mood
disorders of more extreme forms of anxiety as
are often seen in patients with panic disorder or
obsessive–compulsive disorder or that the effect
might exist over a shorter lag period than the
fairly coarse time intervals we were required to
use in the NCS in order to have adequate
statistical power to plot time trends.
Finally, we found that active social phobia is
a more powerful predictor of depressive dis-
orders than history of remitted social phobia. It
is important to note that this specification is not
found in all analyses of co-morbidity. For
example, a parallel NCS investigation of panic
and depression found that remitted panic is as
important as active panic in predicting the
subsequent onset of mood disorders (Kessler et
al. 1999). The fact that this is not the case for
social phobia – that risk of mood disorders is
substantially reduced when the social phobia
remits – raises the possibility that successful
treatment of social phobia might represent a
practical opportunity for the primary prevention
of secondary mood disorders (Kessler & Price,
1993). A potentially feasible way to evaluate this
possibility would be to carry out a long-term
comparative follow-up evaluation of pure social
phobics who participated either in the exper-
imental or control arms of treatment trials for
social phobia to evaluate whether those in
treatment had a reduced risk of subsequent
mood disorders than those in the control arm.
Implications
Previous NCS analyses have documented that
social phobia is a commonly occurring and
seriously impairing disorder that usually has an
early age of onset and is often associated with
high risk of chronicity and secondary co-
morbidity (Kessler et al. 1998b). Another im-
portant result from previous NCS analyses is
that social phobics seldom seek professional
treatment unless they also suffer from some
other co-morbid disorder (Kessler et al. 1999).
This combination of high prevalence, early
onset, chronicity, impairment, risk of secondary
co-morbidity, and low probability of treatment
makes social phobia an important disorder from
a public health perspective. Yet, as noted in the
introduction, many people are unaware of the
importance of social phobia. This is presumably
due to the fact that social phobia is under
diagnosed (Liebowitz et al. 1985; Weiller et al.
1996; Fones et al. 1998) and incorrectly regarded
as not seriously impairing (Hirschfeld, 1995;
Judd, 1994; Wittchen & Beloch, 1996).
Early outreach and intervention with social
phobics prior to the onset of co-morbid disorders
is an appealing strategy in that it would reduce
treatment complexity. Our analysis of time lags
suggests that the typical primary social phobic
suffers for more than a decade before the onset
of secondary mood disorder, providing a very
wide window of opportunity for intervention.
Intervention during this period might also
prevent subsequent mood disorders. Treatment
of social phobics with numerous fears appears
to be of primary importance here both because
this generalized subtype is the most impaired
(Kessler et al. 1998b) and because it is most
strongly related to subsequent onset and severity
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of mood disorders. Given our prediction that
roughly 10% of mood disorders might be
prevented by successful early intervention with
social phobia and the finding that socially phobic
depressives have twice as many impairments and
two-thirds more episodes as depressives without
social phobia, such focused interventions with
generalized social phobics could well reduce the
point prevalence of seriously impairing mood
disorders by as much as one-fourth. This
substantial potential secondary effect, when
combined with the realization that generalized
social phobia is highly impairing in its own
right, argues strongly for future consideration of
this disorder as a public health intervention
target.
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